We are live on
!
Find out more
Syndax Pharmaceuticals
SNDX
SNDX
121 hedge funds and large institutions have $1.02B invested in Syndax Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 48 increasing their positions, 36 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
909% more call options, than puts
Call options by funds: $3.85M | Put options by funds: $381K
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
33% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 36
8% more capital invested
Capital invested by funds: $943M → $1.02B (+$74.4M)
0.97% less ownership
Funds ownership: 99.19% → 98.21% (-0.97%)
11% less funds holding
Funds holding: 136 → 121 (-15)
46% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 24
Holders
121
Holders Change
-15
Holders Change %
-11.03%
% of All Funds
2.04%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
13
Increased
48
Reduced
36
Closed
24
Calls
$3.85M
Puts
$381K
Net Calls
+$3.46M
Net Calls Change
+$1.93M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$22.9M |
| 2 |
DM
Deerfield Management
New York
|
+$18.5M |
| 3 |
EP
Eversept Partners
New York
|
+$16.6M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$10.4M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$9.65M |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$24.4M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$20.2M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$8.43M |
| 4 |
Morgan Stanley
New York
|
-$6.76M |
| 5 |
Millennium Management
New York
|
-$6.69M |
